A closer look at LATE: a Case Report on a subtly evolving neurodegenerative disorder
Neurological Sciences · 2026
DOI: 10.1007/s10072-026-09486-3 ↗Kurz gefasst
Fallbericht in der Zeitschrift Neurological Sciences, 2026. Verfasst von Maria Luisa Di Giesi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine and Surgery, Unit of Neurology, Neurophysiology, Neurobiology and Psychiatry, Fondazione Policlinico Campus Bio-Medico Di Roma…. Hauptthemen laut MEDLINE: TDP-43 Proteinopathies, Neurodegenerative Diseases. Die Arbeit nennt 11 Literaturangaben.
Abstract (Originalsprache)
Objectives
Limbic-predominant age-related TDP-43 encephalopathy (LATE) often presents in older adults with a hippocampal-type amnestic syndrome that is clinically indistinguishable from Alzheimer’s disease (AD). In the era of anti-amyloid therapies, misdiagnosis carries therapeutic consequences.
Methods
Single-patient case report. The patient provided written informed consent and all data included in this paper are de-identified.
Results
A 71-year-old with isolated episodic memory impairment underwent neuropsychological testing, cerebrospinal fluid (CSF) AD biomarkers, and ^18F-FDG PET in 2021. Baseline findings showed preserved global cognition, negative AD biomarkers, and mild bilateral medial temporal hypometabolism. Over the subsequent years, episodic memory declined, while daily function and other cognitive domains remained intact. MRI demonstrated bilateral medial temporal atrophy. Repeat CSF examination showed negative AD biomarkers, whereas NfL levels were markedly elevated. On repeat ^18F-FDG PET, bilateral medial temporal hypometabolism progressed, while inferolateral temporal metabolism—usually reduced in AD—remained preserved.
Discussion
The slowly progressing isolated amnestic profile, medial temporal–predominant neurodegeneration, high CSF NfL level, and persistently negative AD biomarkers supported the diagnosis of LATE. LATE should be actively considered in elderly patients with a hippocampal-type amnestic syndrome and negative AD biomarkers. This requires a high index of suspicion, but it is increasingly critical to avoid ineffective therapies and to refine clinical trial selection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine and Surgery, Unit of Neurology, Neurophysiology, Neurobiology and Psychiatry, Fondazione Policlinico Campus Bio-Medico Di Roma, Università Campus Bio-Medico Di Roma, Via Alvaro del Portillo, 21-00…
- Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, 200-00128, Rome, Italy. f.motolese@policlinicocampus.it.
- Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, 200-00128, Rome, Italy.
- Department of Nuclear Medicine, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, 200-00128, Rome, Italy.
Zitieren
APA
Di Giesi, M. L., Motolese, F., Norata, D., Sapio, E., Selvaggi, S. A., Meduri, G. M., Capone, F., Pilato, F., & Di Lazzaro, V. (2026). A closer look at LATE: a Case Report on a subtly evolving neurodegenerative disorder. Neurological Sciences. https://doi.org/10.1007/s10072-026-09486-3
Vancouver
Di Giesi ML, Motolese F, Norata D, Sapio E, Selvaggi SA, Meduri GM, et al. A closer look at LATE: a Case Report on a subtly evolving neurodegenerative disorder. Neurological Sciences. 2026. doi:10.1007/s10072-026-09486-3
BibTeX
@article{DiGiesi2026,
author = {Di Giesi, Maria Luisa and Motolese, Francesco and Norata, Davide and Sapio, Elisabetta and Selvaggi, Silvia Antonella and Meduri, Guido Maria and Capone, Fioravante and Pilato, Fabio and Di Lazzaro, Vincenzo},
title = {A closer look at LATE: a Case Report on a subtly evolving neurodegenerative disorder},
journal = {Neurological Sciences},
year = {2026},
doi = {10.1007/s10072-026-09486-3}
}
EUVIMED